← Back to Search

Cancer Vaccine

36g of strawberry for Insulin Resistance (STRW Trial)

N/A
Recruiting
Led By Britt Burton-Freeman, PhD
Research Sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Men or women 20-60 years of age
Judged to be in good health with no clinical evidence of cardiovascular, metabolic, respiratory, renal, gastrointestinal, or hepatic disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 4 weeks
Awards & highlights

STRW Trial Summary

This trial will study how strawberries can help improve immune and vascular systems to reduce inflammation, improve endothelial function & insulin sensitivity.

Who is the study for?
This trial is for individuals with prediabetes who may have insulin sensitivity issues, inflammation, or are at risk of developing diabetes. Participants should not have any allergies to strawberries and must be willing to consume strawberry powder or a control powder daily.Check my eligibility
What is being tested?
The study tests the effects of different doses of freeze-dried whole strawberry powder (12g and 36g) versus a control (0g), on immune and vascular health over four weeks. It measures how strawberries might improve inflammation markers, blood sugar regulation, and oxidative stress defense.See study design
What are the potential side effects?
Potential side effects from consuming high doses of strawberry powder could include allergic reactions in sensitive individuals or gastrointestinal discomfort. However, strawberries are generally considered safe with minimal risks when consumed as part of a regular diet.

STRW Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

STRW Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in primary clinical marker of inflammation IL-6
Changes in plasma biomarkers and measures of inflammation: NF-κB activation/suppression
Secondary outcome measures
Change flow mediated dilation (FMD) before and after four weeks strawberry intake compared to control
Change in 10-day Glucose average
Change in Beta cell function using Liquid Meal Tolerance Test (LMTT).
+5 more

STRW Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: 36g of strawberryExperimental Treatment1 Intervention
High dose intervention
Group II: 12g of strawberryExperimental Treatment1 Intervention
Low dose intervention
Group III: 0g of strawberryPlacebo Group1 Intervention
Control

Find a Location

Who is running the clinical trial?

Clinical Nutrition Research Center, Illinois Institute of TechnologyLead Sponsor
53 Previous Clinical Trials
2,854 Total Patients Enrolled
3 Trials studying Insulin Resistance
161 Patients Enrolled for Insulin Resistance
Britt Burton-Freeman, PhDPrincipal InvestigatorIllinois Institute of Technology
1 Previous Clinical Trials
33 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the patient cohort size for this clinical trial?

"Affirmative. According to clinicaltrials.gov, this medical experiment is still recruiting patients and was posted on August 31st 2022; its details most recently updated on December 13th 2023. A total of 66 participants are needed across 1 site for the trial's completion."

Answered by AI

Is it possible for me to enroll in this research initiative?

"To be eligible for this medical trial, individuals should possess an appropriate degree of insulin sensitivity and must lie between the ages of 20 to 60. The research team is currently in search of 66 participants."

Answered by AI

Are older adults eligible to participate in the clinical trial?

"This experiment is recruiting individuals from the age of majority to a maximum of 60 years old."

Answered by AI

Are there any vacancies available to join this research program?

"Affirmative. According to clinicaltrials.gov, the current trial was initially advertised on August 31st 2022 and most recently updated on December 13th 2023. A total of 66 participants are required from a single site for this medical experiment."

Answered by AI

What is the main goal of this clinical experiment?

"The Clinical Nutrition Research Center, Illinois Institute of Technology is the primary sponsor for this trial. They will be assessing changes in plasma biomarkers and measures of inflammation as well as secondary outcomes such as insulin fractional disappearance rate (HOMA-%S), fasting lipids, and insulin sensitivity index over a baseline to 4 week period following strawberry intake at 1 or 3 cups FWeq per day versus 0 cup control group. An IVGTT assessment may also take place amongst a subset if there are no supply chain issues with sterile dextrose."

Answered by AI

Who else is applying?

What site did they apply to?
Clinical Nutrition Research Center
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Understanding Dose Related Effects of Strawberry
Britt Marie Burton-Freeman 2022. "Understanding Dose Related Effects of Strawberry". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06173765.
All > Chicago
~26 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top